In conclusion, we demonstrated that the incorporation of the LNGFR marker gene directly in the CAR sequence allows for a single molecule to work as a therapeutic and as a selection/tracking gene and shows an increased efficacy/safety profile compared to the IgG1-CH2CH3 spacer
In this issue of Cancer Cell, Zhao and colleagues test various chimeric antigen receptor (CAR) T cel...
Targeting disialoganglioside (GD2) on neuroblastoma (NB) with T cells expressing a first-generation ...
Chimeric antigen receptor (CAR) T cell technology has ushered in a new era of immunotherapy, enablin...
Chimeric antigen receptor (CAR) T-cell therapy has been shown to be dramatically effective in the tr...
Chimeric antigen receptor (CAR)-expressing T cells are a promising therapeutic option for patients w...
Chimeric antigen receptor (CAR)-T cell immunotherapy is at the forefront of innovative cancer therap...
Purpose: A delay in encountering the cognate antigen while in the circulation, and the suboptimal co...
© 2017 Dr. Carmen YongCompleted under a Cotutelle arrangement between the University of Melbourne an...
2019-04-19Adoptive transfer of chimeric antigen receptor (CAR) engineered T cells is an emerging can...
Chimeric Antigen Receptor (CAR) T cells are an emergent immunotherapeutic class of agents gaining re...
Purpose: Va24-invariant natural killer T cells (NKT) are attractive carriers for chimeric antigen re...
Chimeric Antigen Receptor (CAR) T cell therapy is a revolutionary treatment option for cancer therap...
In recent years, immunotherapy has revolutionized cancer treatment by prolonging survival and even c...
Immunotherapies have emerged as a viable treatment option in cancer, by harnessing the natural abili...
Cancer immunotherapy has recently made remarkable clinical progress. Adoptive transfer of T-cells en...
In this issue of Cancer Cell, Zhao and colleagues test various chimeric antigen receptor (CAR) T cel...
Targeting disialoganglioside (GD2) on neuroblastoma (NB) with T cells expressing a first-generation ...
Chimeric antigen receptor (CAR) T cell technology has ushered in a new era of immunotherapy, enablin...
Chimeric antigen receptor (CAR) T-cell therapy has been shown to be dramatically effective in the tr...
Chimeric antigen receptor (CAR)-expressing T cells are a promising therapeutic option for patients w...
Chimeric antigen receptor (CAR)-T cell immunotherapy is at the forefront of innovative cancer therap...
Purpose: A delay in encountering the cognate antigen while in the circulation, and the suboptimal co...
© 2017 Dr. Carmen YongCompleted under a Cotutelle arrangement between the University of Melbourne an...
2019-04-19Adoptive transfer of chimeric antigen receptor (CAR) engineered T cells is an emerging can...
Chimeric Antigen Receptor (CAR) T cells are an emergent immunotherapeutic class of agents gaining re...
Purpose: Va24-invariant natural killer T cells (NKT) are attractive carriers for chimeric antigen re...
Chimeric Antigen Receptor (CAR) T cell therapy is a revolutionary treatment option for cancer therap...
In recent years, immunotherapy has revolutionized cancer treatment by prolonging survival and even c...
Immunotherapies have emerged as a viable treatment option in cancer, by harnessing the natural abili...
Cancer immunotherapy has recently made remarkable clinical progress. Adoptive transfer of T-cells en...
In this issue of Cancer Cell, Zhao and colleagues test various chimeric antigen receptor (CAR) T cel...
Targeting disialoganglioside (GD2) on neuroblastoma (NB) with T cells expressing a first-generation ...
Chimeric antigen receptor (CAR) T cell technology has ushered in a new era of immunotherapy, enablin...